PODD - INSULET CORP

QQQ $ 622.77 $ 3.98 (0.64 %)

DIA $ 473.57 $ 1.77 (0.38 %)

SPY $ 680.93 $ 3.75 (0.55 %)

TLT $ 89.56 $ 0.07 (0.08 %)

GLD $ 378.17 $ 2.24 (0.6 %)

Previous Close

$ 319.82

Open

$ 320.63

Bid

$ 321.74 x 23

Ask

$ 322.18 x 4

Day's Range

$ 312.06 - $ 321.75

52 Week Range

$ 230.05 - $ 353.50

Volume

677,167

Average Volume

Market Cap

22.5B

Beta (5Y Monthly)

$ 1.08

PE Ratio (TTM)

$ 91.38

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	02-20-2025	12-31-2024	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	02-23-2024	12-31-2023	10-K
9	11-02-2023	09-30-2023	10-Q
10	08-08-2023	06-30-2023	10-Q
11	05-05-2023	03-31-2023	10-Q
12	02-24-2023	12-31-2022	10-K
13	11-04-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-23-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-07-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-07-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	02-26-2020	12-31-2019	10-K
25	11-06-2019	09-30-2019	10-Q
26	08-06-2019	06-30-2019	10-Q
27	05-03-2019	03-31-2019	10-Q
28	02-26-2019	12-31-2018	10-K
29	11-02-2018	09-30-2018	10-Q
30	08-02-2018	06-30-2018	10-Q
31	05-04-2018	03-31-2018	10-Q
32	02-22-2018	12-31-2017	10-K
33	11-03-2017	09-30-2017	10-Q
34	08-04-2017	06-30-2017	10-Q
35	05-09-2017	03-31-2017	10-Q
36	02-28-2017	12-31-2016	10-K
37	11-04-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	04-29-2016	03-31-2016	10-Q
40	02-29-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Canaccord Genuity Maintains Buy on Insulet...
11/07/2025 22:04:37

Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $399 ...

RBC Capital Maintains Outperform on Insule...
11/07/2025 19:08:17

RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $365 to ...

Wells Fargo Maintains Overweight on Insule...
11/07/2025 18:45:55

Wells Fargo analyst Lawrence Biegelsen maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $3...

UBS Maintains Neutral on Insulet, Raises P...
11/07/2025 17:48:28

UBS analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Neutral and raises the price target from $320 to $355.

Truist Securities Reiterates Buy on Insule...
11/07/2025 16:31:48

Truist Securities analyst Richard Newitter reiterates Insulet (NASDAQ:PODD) with a Buy and raises the price target from $365...

Barclays Maintains Equal-Weight on Insulet...
11/07/2025 15:27:21

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $301 to $316.

Jefferies Maintains Buy on Insulet, Raises...
11/06/2025 21:35:26

Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and raises the price target from $375 to $400.

Insulet Sees Q4 Sales $746.875M-$764.800M ...
11/06/2025 11:44:20

2025 Outlook:For the quarter and year ending December 31, 2025, the Company is providing the following guidance (revenue in con...

Insulet Raises FY2025 Sales Guidance from ...
11/06/2025 11:33:23

2025 Outlook:For the quarter and year ending December 31, 2025, the Company is providing the following guidance (revenue in con...

Insulet Q3 Adj. EPS $1.24 Beats $1.14 Esti...
11/06/2025 11:30:59

Insulet (NASDAQ:PODD) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.14 by 8.96...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

Barclays Maintains Equal-Weight on Insulet...
11/05/2025 17:31:58

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and raises the price target from $300 to $301.

Examining the Future: Insulet's Earnings O...
11/05/2025 15:02:22

insulet-uber-and-a-financial-stock-on-cnbcs-final-trades

Insulet, Uber And A Financial Stock On CNB...
11/05/2025 13:26:18

Joseph Terranova of Virtus Investment Partners named Insulet Corp., a maker of wearable devices for insulin management, as his ...

CNBC Halftime Report Final Trades: Uber Te...
11/04/2025 18:01:05

Peering Into Insulet Corp's Recent Short I...
10/31/2025 15:00:52

$100 Invested In Insulet 15 Years Ago Woul...
10/30/2025 16:15:49

Here's How Much You Would Have Made Owning...
10/21/2025 20:30:26

Stifel Reinstates Buy on Insulet, Announce...
10/21/2025 14:07:22

Stifel analyst Jonathan Block reinstates Insulet (NASDAQ:PODD) with a Buy and announces $370 price target.

Price Over Earnings Overview: Insulet
09/30/2025 18:00:26